TKAI

Tokai Pharmaceuticals IncCIK 1404281 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TKAI PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TKAI

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Cohen Cheryl	Director	2	$0	$0	2016-06-16
Kessler David A.	Director	2	$0	$0	2016-06-15
Yanchik Joseph A., III	Director	2	$0	$0	2016-06-15
Buckley Stephen Jr.	Director	5	$79.7K	$0	2016-06-15
Harrison Seth Loring	Director, 10% Owner	12	$5.44M	$0	2016-06-15
BARBERICH TIMOTHY J	Director	5	$0	$0	2016-06-15
Morrison Jodie Pope	President and CEO	27	$0	$392.4K	2016-01-08
Kalowski Lee	Chief Financial Officer	7	$0	$174.5K	2015-12-15
McBride John S.	Chief Operating Officer	14	$0	$315.2K	2015-12-15
Ferrante Karen Jean	Head Res. & Dev. & Chief Med.	1	$0	$0	2015-12-15
Quirk Gerald E	General Counsel, Executive VP	2	$0	$0	2015-12-15
NOVARTIS AG	10% Owner	13	$4.88M	$1.75M	2015-07-15
Novartis Bioventures Ltd	10% Owner	2	$0	$411.8K	2015-06-16
Apple Tree Partners II - Annex, L.P.	Director, 10% Owner	4	$3.56M	$0	2014-09-22
Satter Muneer A	10% Owner	6	$2.25M	$0	2014-09-22
APPLE TREE PARTNERS II LP	Director, 10% Owner	8	$0	$0	2014-09-22

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Cohen Cheryl	Director	A Award deriv	2016-06-16	2016-06-16	12,000	—	$0	12,000	SEC↗
Harrison Seth Loring	Director, 10% Owner	A Award deriv	2016-06-15	2016-06-16	12,000	—	$0	12,000	SEC↗
BARBERICH TIMOTHY J	Director	A Award deriv	2016-06-15	2016-06-16	12,000	—	$0	12,000	SEC↗
Buckley Stephen Jr.	Director	A Award deriv	2016-06-15	2016-06-16	12,000	—	$0	12,000	SEC↗
Kessler David A.	Director	A Award deriv	2016-06-15	2016-06-16	12,000	—	$0	12,000	SEC↗
Yanchik Joseph A., III	Director	A Award deriv	2016-06-15	2016-06-16	12,000	—	$0	12,000	SEC↗
Buckley Stephen Jr.	Director	P Buy	2016-03-15	2016-03-15	8,000	$5.74	$45.9K	11,000	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2016-01-08	2016-01-08	8,015	—	$0	0	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2016-01-08	2016-01-08	20,000	—	$0	37,878	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2016-01-08	2016-01-08	20,000	$1.37	$27.4K	57,566	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2016-01-08	2016-01-08	8,015	$0.63	$5.0K	37,566	SEC↗
McBride John S.	Chief Operating Officer	A Award deriv	2015-12-15	2015-12-17	62,000	—	$0	62,000	SEC↗
Quirk Gerald E	General Counsel, Executive V	A Award deriv	2015-12-15	2015-12-17	62,000	—	$0	62,000	SEC↗
Kalowski Lee	Chief Financial Officer	A Award deriv	2015-12-15	2015-12-17	62,000	—	$0	62,000	SEC↗
Morrison Jodie Pope	President and CEO	A Award deriv	2015-12-15	2015-12-17	189,000	—	$0	189,000	SEC↗
Ferrante Karen Jean	Head Res. & Dev. & Chief Med	A Award deriv	2015-12-15	2015-12-17	62,000	—	$0	62,000	SEC↗
Buckley Stephen Jr.	Director	P Buy	2015-11-11	2015-11-12	3,000	$11.25	$33.8K	3,000	SEC↗
McBride John S.	Chief Operating Officer	M Exercise deriv	2015-09-21	2015-09-22	13,500	—	$0	186,678	SEC↗
McBride John S.	Chief Operating Officer	M Exercise	2015-09-21	2015-09-22	13,500	$4.19	$56.6K	13,500	SEC↗
McBride John S.	Chief Operating Officer	S Sale	2015-09-21	2015-09-22	13,500	$14.01	$189.1K	0	SEC↗
Kalowski Lee	Chief Financial Officer	S Sale	2015-09-08	2015-09-08	4,668	$13.13	$61.3K	40,953	SEC↗
Kalowski Lee	Chief Financial Officer	S Sale	2015-09-02	2015-09-04	2,158	$12.96	$28.0K	45,621	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-29	2015-07-30	564	—	$0	312,736	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-29	2015-07-30	7,000	—	$0	8,015	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-29	2015-07-30	3,000	—	$0	57,878	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-29	2015-07-30	564	$1.58	$891	20,115	SEC↗
Morrison Jodie Pope	President and CEO	S Sale	2015-07-29	2015-07-30	564	$13.70	$7.7K	19,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-29	2015-07-30	7,000	$0.63	$4.4K	26,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-29	2015-07-30	3,000	$1.37	$4.1K	29,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-28	2015-07-30	12,000	—	$0	313,300	SEC↗
Morrison Jodie Pope	President and CEO	S Sale	2015-07-28	2015-07-30	12,000	$13.70	$164.4K	19,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-28	2015-07-30	12,000	$1.58	$19.0K	31,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-22	2015-07-24	2,574	—	$0	0	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-07-22	2015-07-24	7,426	—	$0	15,015	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-22	2015-07-24	2,574	$2.31	$5.9K	12,125	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-07-22	2015-07-24	7,426	$0.63	$4.7K	19,551	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-07-15	2015-07-17	3,566	$14.26	$50.9K	4,493,458	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-07-14	2015-07-15	27,861	$14.41	$401.5K	4,497,024	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-07-13	2015-07-15	20,611	$14.20	$292.7K	4,524,885	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-06-29	2015-06-30	8,000	—	$0	325,300	SEC↗
Morrison Jodie Pope	President and CEO	S Sale	2015-06-29	2015-06-30	8,000	$13.70	$109.6K	9,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-06-29	2015-06-30	8,000	$1.58	$12.6K	17,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise deriv	2015-06-26	2015-06-30	8,000	—	$0	333,300	SEC↗
Morrison Jodie Pope	President and CEO	S Sale	2015-06-26	2015-06-30	8,000	$13.83	$110.6K	9,551	SEC↗
Morrison Jodie Pope	President and CEO	M Exercise	2015-06-26	2015-06-30	8,000	$1.58	$12.6K	17,551	SEC↗
McBride John S.	Chief Operating Officer	M Exercise deriv	2015-06-24	2015-06-24	300	—	$0	200,178	SEC↗
McBride John S.	Chief Operating Officer	S Sale	2015-06-24	2015-06-24	300	$14.20	$4.3K	0	SEC↗
McBride John S.	Chief Operating Officer	M Exercise	2015-06-24	2015-06-24	300	$4.19	$1.3K	300	SEC↗
McBride John S.	Chief Operating Officer	M Exercise deriv	2015-06-23	2015-06-24	6,700	—	$0	200,478	SEC↗
McBride John S.	Chief Operating Officer	S Sale	2015-06-23	2015-06-24	6,700	$14.00	$93.8K	0	SEC↗
McBride John S.	Chief Operating Officer	M Exercise	2015-06-23	2015-06-24	6,700	$4.19	$28.1K	6,700	SEC↗
McBride John S.	Chief Operating Officer	M Exercise deriv	2015-06-22	2015-06-24	2,000	—	$0	207,178	SEC↗
McBride John S.	Chief Operating Officer	M Exercise	2015-06-22	2015-06-24	2,000	$4.19	$8.4K	2,000	SEC↗
McBride John S.	Chief Operating Officer	S Sale	2015-06-22	2015-06-24	2,000	$14.02	$28.0K	0	SEC↗
BARBERICH TIMOTHY J	Director	A Award deriv	2015-06-17	2015-06-19	12,000	—	$0	12,000	SEC↗
Harrison Seth Loring	Director, 10% Owner	A Award deriv	2015-06-17	2015-06-19	12,000	—	$0	12,000	SEC↗
Kessler David A.	Director	A Award deriv	2015-06-17	2015-06-19	12,000	—	$0	12,000	SEC↗
Yanchik Joseph A., III	Director	A Award deriv	2015-06-17	2015-06-19	12,000	—	$0	12,000	SEC↗
Buckley Stephen Jr.	Director	A Award deriv	2015-06-17	2015-06-19	12,000	—	$0	12,000	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2015-06-16	2015-06-18	1,120	$14.27	$16.0K	4,545,496	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-06-12	2015-06-16	5,919	$14.20	$84.0K	4,561,393	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2015-06-11	2015-06-12	27,875	$14.20	$395.8K	4,567,312	SEC↗
Quirk Gerald E	General Counsel, Executive V	A Award deriv	2015-05-26	2015-05-28	214,605	—	$0	214,605	SEC↗
Kalowski Lee	Chief Financial Officer	S Sale	2015-04-16	2015-04-20	4,567	$13.00	$59.4K	47,779	SEC↗
Cohen Cheryl	Director	A Award deriv	2015-04-09	2015-04-13	25,000	—	$0	25,000	SEC↗
Kalowski Lee	Chief Financial Officer	S Sale	2015-04-02	2015-04-06	2,258	$11.45	$25.9K	52,346	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-03-19	2015-03-20	46,141	$14.50	$669.0K	4,595,187	SEC↗
NOVARTIS AG	10% Owner	S Sale	2015-03-18	2015-03-20	3,000	$14.50	$43.5K	4,641,328	SEC↗
Buckley Stephen Jr.	Director	A Award deriv	2015-01-08	2015-01-12	25,000	—	$0	25,000	SEC↗
McBride John S.	Chief Operating Officer	A Award deriv	2014-10-15	2014-10-17	50,671	—	$0	50,671	SEC↗
Morrison Jodie Pope	President and CEO	A Award deriv	2014-10-15	2014-10-17	134,134	—	$0	134,134	SEC↗
Morrison Jodie Pope	President and CEO	A Award deriv	2014-09-22	2014-09-24	165,251	—	$0	165,251	SEC↗
BARBERICH TIMOTHY J	Director	C Conversion deriv	2014-09-22	2014-09-24	809,955	—	$0	0	SEC↗
BARBERICH TIMOTHY J	Director	C Conversion deriv	2014-09-22	2014-09-24	457,731	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	1,539,643	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	15,064,469	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	13,222,826	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	15,396,431	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	644,786	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	14,604,833	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	8,711,335	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	1,539,643	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	24,046,035	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	24,199,308	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	798,067	—	$0	0	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	4,500,000	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	4,500,000	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	798,067	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	644,786	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	8,711,335	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	1,539,643	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	13,370,422	—	$0	0	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	14,604,833	—	$0	0	SEC↗
Apple Tree Partners II - Annex	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	24,199,308	—	$0	0	SEC↗
Apple Tree Partners II - Annex	Director, 10% Owner	C Conversion deriv	2014-09-22	2014-09-24	10,675,613	—	$0	0	SEC↗
Satter Muneer A	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	4,577,315	—	$0	0	SEC↗
Satter Muneer A	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	8,013,003	—	$0	0	SEC↗
Satter Muneer A	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	3,931,085	—	$0	0	SEC↗
Satter Muneer A	10% Owner	C Conversion deriv	2014-09-22	2014-09-24	457,728	—	$0	0	SEC↗
BARBERICH TIMOTHY J	Director	C Conversion	2014-09-22	2014-09-24	121,077	—	$0	121,077	SEC↗
NOVARTIS AG	10% Owner	C Conversion	2014-09-22	2014-09-24	4,319,328	—	$0	4,319,328	SEC↗
NOVARTIS AG	10% Owner	P Buy	2014-09-22	2014-09-24	325,000	$15.00	$4.88M	4,644,328	SEC↗
Harrison Seth Loring	Director, 10% Owner	C Conversion	2014-09-22	2014-09-24	7,549,570	—	$0	7,549,579	SEC↗
Harrison Seth Loring	Director, 10% Owner	P Buy	2014-09-22	2014-09-24	362,500	$15.00	$5.44M	7,912,079	SEC↗
APPLE TREE PARTNERS II LP	Director, 10% Owner	C Conversion	2014-09-22	2014-09-24	4,218,632	—	$0	4,218,641	SEC↗
Apple Tree Partners II - Annex	Director, 10% Owner	P Buy	2014-09-22	2014-09-24	237,500	$15.00	$3.56M	3,568,438	SEC↗
Apple Tree Partners II - Annex	Director, 10% Owner	C Conversion	2014-09-22	2014-09-24	3,330,938	—	$0	3,330,938	SEC↗
Satter Muneer A	10% Owner	P Buy	2014-09-22	2014-09-24	150,000	$15.00	$2.25M	1,771,688	SEC↗
Satter Muneer A	10% Owner	C Conversion	2014-09-22	2014-09-24	1,621,688	—	$0	1,621,688	SEC↗
Kalowski Lee	Chief Financial Officer	A Award deriv	2014-09-17	2014-09-18	218,417	—	$0	218,417	SEC↗
Kalowski Lee	Chief Financial Officer	A Award	2014-09-17	2014-09-18	54,604	—	$0	54,604	SEC↗
NOVARTIS AG	10% Owner	S Sale	2014-06-15	2015-06-16	14,777	$14.20	$209.8K	4,546,616	SEC↗